Tackling the taboo: a sensible prescription for appropriate cannabis use in fibromyalgia
Pain Manag
.
2022 Mar;12(2):117-122.
doi: 10.2217/pmt-2021-0096.
Epub 2021 Nov 8.
Authors
Alexis Holman
1
,
Kevin F Boehnke
2
Affiliations
1
Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI 48109, USA.
2
Anesthesiology Department, Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI 48106, USA.
PMID:
34743594
DOI:
10.2217/pmt-2021-0096
No abstract available
Keywords:
cannabidiol; cannabis; chronic pain; fibromyalgia; guidance; tetrahydrocannabinol.
Publication types
Editorial
MeSH terms
Cannabis*
Fibromyalgia* / drug therapy
Humans
Medical Marijuana* / therapeutic use
Prescriptions
Taboo
Substances
Medical Marijuana
Grants and funding
K01 DA049219/DA/NIDA NIH HHS/United States
T32 AR007080/AR/NIAMS NIH HHS/United States